Načítá se...
Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products
Current European pharmaceutical legislation is not adequate to meet advances in science and technologies that will lead to rapid development of custom-made medicines. Using existing legislation for custom-made medical devices as a template and anti-sense oligonucleotides as model medicinal products,...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Science Inc
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4093919/ https://ncbi.nlm.nih.gov/pubmed/24750439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12250 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|